Currently Closed – We are no longer accepting or processing applications for new or renewal patients.
The PAN Foundation’s Systemic Lupus Erythematosus fund is currently closed. As of August 15, 2019, The Assistance Fund is accepting applications.
For current information, log in to FundFinder.
Maximum Award Level
$6,300 per year. Patients may apply for a second grant during their eligibility period subject to availability of funding.
- The patient must be getting treatment for systemic lupus erythematosus.
- The patient must have health insurance that covers his or her qualifying medication or product.
- The patient’s medication or product must be listed on PAN’s list of covered medications.
- The patient’s income must fall at or below 500% of the Federal Poverty Level.
- The patient must reside and receive treatment in the United States or U.S. territories. (U.S. citizenship is not a requirement.)
See the list of medications covered in this program
- Azasan (azathioprine)
- Azathioprine (azathioprine)
- Azathioprine Sodium (azathioprine sodium)
- Benlysta (belimumab)
- Betamethasone Acetate-sod Phos (betamethasone acetate and sodium phos in sterile water/pf)
- Betamethasone Sod Phos-acetate (betamethasone acetate/betamethasone sodium phosphate)
- Cambia (diclofenac potassium)
- Celebrex (celecoxib)
- Cellcept (mycophenolate mofetil)
- Cellcept (mycophenolate mofetil hcl)
- Chloroquine Phosphate (chloroquine phosphate)
- Cyclophosphamide (cyclophosphamide)
- Cyclosporine (cyclosporine)
- Cyclosporine Modified (cyclosporine, modified)
- Deltasone (prednisone)
- Diflunisal (diflunisal)
- Durlaza (aspirin)
- Gengraf (cyclosporine, modified)
- Hydroxychloroquine Sulfate (hydroxychloroquine sulfate)
- Imuran (azathioprine)
- Indocin (indomethacin)
- Kenalog-40 (triamcinolone acetonide)
- Ketoprofen (ketoprofen)
- Lodine (etodolac)
- Methotrexate (methotrexate sodium)
- Methylprednisolone Acetate (methylprednisolone acetate)
- Methylprednisolone Sodium Succ (methylprednisolone sodium succinate)
- Mycophenolate Mofetil (mycophenolate mofetil)
- Naproxen (naproxen)
- Naproxen Sodium Cr (naproxen sodium)
- Naproxen Sodium Ds (naproxen sodium)
- Naproxen Sodium Er (naproxen sodium)
- Neoral (cyclosporine, modified)
- Otrexup (methotrexate/pf)
- Oxaprozin (oxaprozin)
- P-care D40 (methylprednisolone acetate)
- P-care D80 (methylprednisolone acetate)
- Piroxicam (piroxicam)
- Plaquenil (hydroxychloroquine sulfate)
- Prednisone (prednisone)
- Rasuvo (methotrexate/pf)
- Rayos (prednisone)
- Readysharp Methylprednisolone (methylprednisolone acetate)
- Rituxan (rituximab)
- Sandimmune (cyclosporine)
- Solu-medrol (methylprednisolone sodium succinate/pf)
- Sulindac (sulindac)
- Tolmetin Sodium (tolmetin sodium)
- Trexall (methotrexate sodium)
- Triamcinolone Acetonide (triamcinolone acetonide)
- Triamcinolone Diacetate (triamcinolone diacetate in 0.9 % sodium chloride)
- Voltaren-xr (diclofenac sodium)
- Xatmep (methotrexate)
- Zipsor (diclofenac potassium)
- Zorvolex (diclofenac submicronized)
ICD-10: M32.10, M32.11, M32.12, M32.13, M32.14, M32.15, M32.19, M32.8, M32.9
About the Disease:
Systemic lupus erythematosus (SLE), also known as lupus, is an inflammatory disease caused when the immune system attacks its own tissues. SLE is a chronic disease that affects the immune system.
Source: National Institutes of Health